A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia

NCT07100418 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: HRS-7249 Injection
DRUG: Sodium Chloride Injection

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.